Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua R D Pearson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Signal Transduction and Targeted Therapy|December 22, 2017
Targeting cellular pathways in glioblastoma multiformeJoshua R D Pearson, Tarik Regad
FEBS Open Bio|June 15, 2023
Robust formation of optimal single spheroids towards cost-effective in vitro three-dimensional tumor modelsKinana Habra, Joshua R D Pearson, Stéphanie E B McArdle
Biomedicines|August 26, 2023
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate CancerCarles Puig-Saenz, Joshua R D Pearson, Jubini E Thomas, et al.
Frontiers in Immunology|November 12, 2020
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for TreatmentJoshua R D Pearson, Stefania Cuzzubbo, Simon McArthur, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumorsJoshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Signal Transduction and Targeted Therapy|December 22, 2017
Targeting cellular pathways in glioblastoma multiformeJoshua R D Pearson, Tarik Regad
FEBS Open Bio|June 15, 2023
Robust formation of optimal single spheroids towards cost-effective in vitro three-dimensional tumor modelsKinana Habra, Joshua R D Pearson, Stéphanie E B McArdle
Biomedicines|August 26, 2023
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate CancerCarles Puig-Saenz, Joshua R D Pearson, Jubini E Thomas, et al.
Frontiers in Immunology|November 12, 2020
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for TreatmentJoshua R D Pearson, Stefania Cuzzubbo, Simon McArthur, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumorsJoshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, et al.
Pageof 1